To quantitatively assess the role of Candida species in antibiotic-associated diarrhea (AAD), stool samples from a total of 395 patients and control subjects were cultured in differential isolation medium 
). In control subjects, Candida positivity and overgrowth were less common than in all .612 other groups. Production of Sap did not differ between patients with AAD and control subjects ( and , respectively). Data indicate that elevated Candida counts are a result P p .568 P p .590 of antibiotic treatment or diarrhea rather than a cause of AAD.
Oral thrush and esophagitis are the most common pathologic manifestations of Candida infections [1, 2] . The role of Candida in antibiotic-associated diarrhea (AAD) has been debated [3] [4] [5] [6] . Fecal concentrations of Candida species of у10 5 cfu/mL stool have been considered to cause diarrhea in patients after antibiotic therapy. It has been reported that patients who received antibiotics without developing diarrhea had !10 5 cfu Candida fungi/mL stool [3] .
Secreted aspartyl proteinases (Saps) are important virulence factors produced by Candida species. Saps are involved in the adherence of Candida albicans to human mucosa and in the invasion of human tissue. A correlation between expression of Saps and Candida virulence has been demonstrated in oral candidiasis and Candida vaginitis in human immunodeficiency virus (HIV)-infected patients [7] [8] [9] [10] [11] [12] [13] . In Candida-related AAD, active secretion mediated by a fungal toxin or toxinlike substances has been discussed as the pathogenetic mechanism for diarrhea [3, 5, 14, 15] . In C. albicans, 10 different SAP genes have been identified [8] . In Candida tropicalis, weak extracel-lular proteolytic activity has been observed, whereas Candida glabrata has no proteolytic activity on protein agar [16] .
C. albicans is known to produce aspartyl proteinases when grown in medium with protein as the sole source of nitrogen [16] [17] [18] , and expression of the SAP2 gene is principally responsible for the proteolytic activity observed in most strains growing in the yeast form in vitro [19] . Saps also show proteolytic activity in the gastrointestinal tract; SAP expression in oral candidiasis and degradation of gastrointestinal mucin by Saps has been demonstrated [20, 21] . Degradation of gastrointestinal mucin by enzymes has been implicated as a virulence determinant for a number of enteropathogens (e.g., Vibrio cholerae, Shigella species, Helicobacter pylori, and Yersinia enterocolitica) [22] [23] [24] [25] . For C. albicans, which colonizes mucosal surfaces, mucin degradation by SAP2 may allow for closer approximation to epithelial cells and/or modification of cellular surfaces [20] . Higher levels of secretory Candida acid proteinase were found in children with acute and chronic diarrhea than in healthy control subjects [26] .
To elucidate the pathogenetic relevance of Candida species in adult patients with AAD, we performed quantitative stool cultures for Candida species in 395 immunocompetent adults. In addition, the production of Saps was examined.
Methods
Patient selection and collection of stool samples. All patients in a 250-bed medical department were surveyed for diarrhea or for antibiotic treatment in the absence of diarrhea on a daily basis for 11 months. Diarrhea was defined as 13 mushy or watery stools per day [27] . Antibiotic treatment was defined as receiving oral or intravenous antibiotics in therapeutic doses for у1 day. AAD was defined as 13 mushy or watery stools per day during or up to 2 months after antibiotic treatment [27] . Patients were consecutively recruited into 4 study groups until the predetermined numbers necessary for statistical comparison were reached (see statistical analysis below). Patients were included only once during their hospital admission. Stool samples from all patients with diarrhea were cultured for bacterial pathogens (salmonella, shigella, yersinia, and campylobacter) on selective agar, were examined for ova and parasites, and were tested for Clostridium difficile by culture on selective agar and by use of the rapid C. difficile test (BD). Patients with any of these pathogens were excluded from the study. Thus, 395 patients (195 with diarrhea and 200 without) were included in the study and were assigned to 4 groups: (1) The 4 groups did not differ in sex and age distribution. Stool samples from all subjects were collected immediately after a bowel movement and were brought to the laboratory in the same building within 15 min. Samples from stools passed during the night were stored at 4ЊC and were processed the next morning.
Candida cultures and slide smears. The stool samples were diluted 1:10 with saline, were stirred in a stool homogenizer, and again were diluted 1:1000 and 1:10000 with saline. One hundred microliters of each dilution was transferred onto a Candida CHROMagar (BBL) and was plated evenly with a sterile swab. After incubation at 37ЊC for 48 h in ambient air, the Candida colonies were counted and classified as C. albicans, C. glabrata, C. krusei, C. tropicalis, or other Candida species, according to the color of the colonies. A colony count у10 5 cfu/mL stool was classified as "Candida overgrowth," according to Danna et al. [3] . A slide smear of every dilution of the first 100 consecutive stool samples was stained with Gram's stain and was examined by light microscopy for the presence of yeasts and leukocytes. [13] . The medium was adjusted to pH 5.0, was sterilized by filtration (pore size, 0.2 mm), and was added to a stock solution of autoclaved (2%) agar. Proteolysis, indicating enzyme activity, was measured in millimeters and was scored as suggested elsewhere [13] : Ϫ or ‫ע‬ (no visible or a very limited clarification of the agar around the colony was present), 1ϩ (appreciable proteolysis [1-2 mm] was observed), and 2ϩ (agar clarification largely exceeded the margin of the colony [3-5 mm]). C. albicans strain SC5314 and a SAP2 null mutant (provided by B. Hube, University of Hamburg, Germany) were investigated as controls [19] .
Statistical analysis. [13] . When C. glabrata isolates (which are known to be negative on protein agar) were deleted, there was no significant difference in Sap production between the groups ( ). P p .347
Discussion
Candida overgrowth has been postulated to cause AAD [3, 6, 14] . We investigated the presence and quantity of Candida species in patients suspected of having AAD, patients without diarrhea but taking antibiotics, patients with diarrhea but not taking antibiotics, and patients without diarrhea and not taking antibiotics (control subjects). A significantly higher proportion of stool samples from patients receiving antimicrobial therapy and experiencing diarrhea (A ϩ D ϩ group) were positive for Candida species and had higher colony counts than did samples from control subjects (A Ϫ D Ϫ group). In a study by Danna et al. [3] , Candida overgrowth (у10 5 cfu/mL stool) was seen in 7 (29%) of 24 AAD patients. In that study, 0 of 24 patients without diarrhea but receiving antibiotics had Candida overgrowth [3] . However, in our study, 52 (56%) of 93 patients with antibiotics but without diarrhea had Candida overgrowth, and no difference was seen, compared with AAD patients. Since we investigated a nearly 4-fold number of patients (93 vs. 24), the differences between our findings and those of Danna et al. [3] may be due to the larger sample size in our study.
To assess the influence of diarrhea on intestinal Candida counts, we also investigated patients not receiving antibiotic therapy but who had diarrhea (group A Ϫ D ϩ ). In this group, Candida overgrowth (у10 5 cfu/mL stool) was significantly less frequent than in AAD patients, but Candida positivity was not significantly different. Previous studies showed that normal stool flora was markedly decreased in AAD patients. In studies in which the effects of broad-spectrum antibiotics on the composition of intestinal microflora of humans were investigated, a significant inverse correlation between the log of the maximum increase in yeasts and the log of the maximum decrease in anaerobes was observed [3, 14, 28 15] . In that study, the authors presumed that a large majority of the yeasts in stools detected under the microscope were not alive [15] . Our results indicated that great caution should be exercised in interpreting stool samples from patients with AAD and positive for Candida species. The usefulness of analyzing stools for Candida counts by culture or slide smears in these patients is seriously questioned. The absence of leukocytes in samples stained with Gram's stain was consistent with previous findings [3] . Our results also confirmed that Candida species were part of the normal gut flora.
Active secretion mediated by a fungal toxin or toxinlike substances has been discussed as the mechanism for Candida-related AAD [3, 5, 14, 15] . Since Saps are the major virulence factors in Candida infections [9, [29] [30] [31] [32] [33] , we investigated these proteinases in vitro. To date, 10 different SAP genes have been identified in C. albicans [8] . Because Sap has been reported to contribute to tissue damage in a model of human oral candidosis [21] , these proteinases may also damage intestinal epithelial cells. But in 8 patients suspected of having Candida-related AAD, there was no evidence of colitis or cellular damage [14] .
In our study, all investigated C. albicans strains produced Saps, and there was no significant difference between the amount of Saps produced in Candida isolates from AAD patients and control subjects. Higher levels of secretory Candida acid proteinases were found in children with acute and chronic diarrhea than in healthy control subjects [26] . Although Sap levels calculated for the whole group of children with acute or chronic diarrhea were significantly higher than levels in control subjects, this was not the case in single cases. Of 9 Candida isolates, 4 from control subjects (children without diarrhea) had Sap levels comparable to those of children with chronic diarrhea, and 2 of 9 control subjects had levels comparable to those of children with acute diarrhea. Despite these high Sap levels, control subjects did not have diarrhea. This contrasts with findings in previous studies, in which Sap production in symptomatic patients always reached higher levels than in control subjects: Sap production by Candida species from vaginitis patients always exceeded Sap production by Candida from carriers, and Candida strains from oral candidiasis in AIDS patients produced ∼8-fold more Sap than did isolates from control subjects [11, 13] .
Sap production is coherently indicated by the BSA agar test and ELISA [11, 13] . Moreover, high levels of Sap secreted in vitro and detected by BSA agar or ELISA correlated to increased levels of Sap in vivo (e.g., in vaginal fluids from HIVpositive vaginitis patients) [13] . One can speculate that Candida species temporarily produces high levels of Sap in vivo but loses this capability because of, for example, subculturing. In C. albicans isolated from oral cavities, it was shown that elevated Sap production was a stable characteristic. On the other hand, C. albicans isolates with low proteinase production showed stable, low-level Sap production on repeated subcultures [13] .
In summary, the results of our study do not confirm the previously suggested pathogenetic mechanisms of Candida-related AAD [3, 4, 6, 15] . Our data indicate that elevated Candida counts are a result of antibiotic treatment or diarrhea per se rather than a cause of AAD. The production of the major fungal virulence factor Sap in patients with AAD did not differ from that in control subjects, which indicates that this fungal toxin may not be responsible for AAD in adults. Other fungal virulence factors (e.g. phospholipases) warrant further investigation.
